Tagged with P

Lonza Czech Republic Mr. Kužela, you have a very interesting background: from 1993 until 2011, you variously worked for the Staropramen beer factory and its parent organization, StarBev. You identify yourself as an experienced professional in managing the supply chain of FMCG products. How did you come to manage a biotechnology business, and…

CMS Cameron McKenna Czech Republic Mr. Matějovský, let’s begin our discussion with a very simple question. The Czech Republic is quite a small country, and yet it seems to have one of the most complicated pharmaceutical regulatory frameworks in Europe–ensuring, for instance, that market access for drugs can take up to three years longer in…

Servier Czech Republic You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets? The first difference is of course the size of the market—the Czech Republic has a market value of approximately 2Bn…

China Chen Qiyu, chairman of Fosun Pharma, discusses how the company is helping China achieve its ‘Healthy China 2020’ goals as well as its unique business model and company culture. Fosun Pharma is an integrated pharmaceutical company with interests all along the value chain, from API to finished products, distribution, medical…

BeAPP Can you provide us with an overview of BeAPP’s missions & objectives and your role as President of the association? Stefaan Vancayzeele (SV): The primary mission of the Belgian association of pharmaceutical physicians is to support and represent the interests of its members throughout their careers. In addition to this,…

pharma.be Mr Neels, can you please begin by introducing our readers to pharma.be and describe its key activities and vision? pharma.be is the General Association of the Pharmaceutical Industry in Belgium that is currently composed of approximately 140 pharmaceutical companies with operations in Belgium. As a full partner of physicians, pharmacists,…

Hospira Hospira Mexico is not only the control centre for Central America and Caribbean operations, but it is the Latin American regional office. Why was such importance given to Mexico in this respect, and not for example, to Brazil? First of all, the Hospira model is a shared services model. It…

Promomed Mr Vandiest, it’s always a pleasure for us to interview the entrepreneurs behind the businesses we meet. Can you tell us more about the vision behind the creation of Promomed? Since its foundation, Promomed has been focused on providing outsourced sales representative solutions for its clients. Certainly, this is by…

AIFD - Association of Research-Based Pharmaceutical Companies Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our readers and expose the career path that has led you to take the helm of Turkey’s leader in the pharmaceutical…

AIFD - Association of Research-Based Pharmaceutical Companies In an environment where the line between generic and innovator companies is less and less relevant, due to the growing trend of innovators integrating generics products in their portfolio through acquisitions, to what extent has the role of association evolved? Despite the growing trend of integrating innovative products with generics,…

MSD Czech Republic Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment, you were tasked with managing the merger between MSD and Schering-Plough. How challenging was this undertaking, and what were the keys to its success? This was…

Ministry of Health Czech Republic Dr. Heger, you were appointed as the Czech Minister of Health in July of 2010. What challenges did you see for the Czech healthcare system, and what has been your overall vision for reform? I believe that we continue to face the same difficulties today that we have faced for…